Free Shipping on All Orders $75 Or More!

Your Trusted Brand for Over 35 Years

Health Protocols



Abedin M, Tintut Y, Demer LL. Vascular calcification: mechanisms and clinical ramifications. Arterioscler Thromb Vasc Biol. 2004 Jul;24(7):1161-70.

Abrahamsen B. Adverse effects of bisphosphonates. Calcif Tissue Int. 2010 Jun;86(6):421-35.

Adams JS. "Bound" to work: the free hormone hypothesis revisited. Cell. 2005 Sep 9;122(5):647-9.

Adams JE. Quantitative computed tomography. European journal of radiology. Sep 2009;71(3):415-424.

Adler RA, El-Hajj Fuleihan G, Bauer DC, Camacho PM, Clarke BL, Clines GA, . . . Sellmeyer DE. Managing Osteoporosis in Patients on Long-Term Bisphosphonate Treatment: Report of a Task Force of the American Society for Bone and Mineral Research. J Bone Miner Res.Jan 2016;31(1):16-35.

Ahmed LA, Schirmer H, Bjornerem A, Emaus N, Jorgensen L, Stormer J, Joakimsen RM. The gender- and age-specific 10-year and lifetime absolute fracture risk in Tromso, Norway. Eur J Epidemiol. 2009;24(8):441-8. Epub 2009 May 30.

Ailinger RL, Braun MA, Lasus H, Whitt K. Factors influencing osteoporosis knowledge: a community study. J Community Health Nurs. 2005 Fall;22(3):135-42.

Akhter MP, Alvarez GK, Cullen DM, Recker RR. Disuse-related decline in trabecular bone structure. Biomech Model Mechanobiol. 2010 Aug 4.

Akin F, Bastemir M, Alkis E, Kaptanoglu B. SHBG levels correlate with insulin resistance in postmenopausal women. Eur J Intern Med. 2009 Mar;20(2):162-7.

Aloia JF, Patel M, Dimaano R, et al. Vitamin D intake to attain a desired serum 25-hydroxyvitamin D concentration. Am J Clin Nutr. 2008 Jun;87(6):1952-8.

Altundag K. Bisphosphonate-associated orbital inflammation: is it class-specific side effect? Journal of B.U.ON.: official journal of the Balkan Union of Oncology.Nov-Dec 2017;22(6):1603.

Anderson JJ, Anthony MS, Cline JM, Washburn SA, Garner SC. Health potential of soy isoflavones for menopausal women. Public Health Nutr. 1999 Dec;2(4):489-504.

Andreassen TK. The role of plasma-binding proteins in the cellular uptake of lipophilic vitamins and steroids. Horm Metab Res. 2006 Apr;38(4):279-90.

Archer DF. Tissue-selective estrogen complexes: a promising option for the comprehensive management of menopausal symptoms. Drugs Aging. 2010 Jul 1;27(7):533-44.

Atkins G et al. Vitamin K promotes mineralization, osteoblast-to-osteocyte transition, and an anticatabolic phenotype by y-carboxylation-dependent and -independent mechanisms. Am J Physiol Cell Physiol December 2009 vol. 297 no. 6 C1358-C1367

Atteritano M, Mazzaferro S, Frisina A, et al. Genistein effects on quantitative ultrasound parameters and bone mineral density in osteopenic postmenopausal women. Osteoporos Int. 2009 Nov;20(11):1947-54.

Aydin H, Deyneli O, Yavuz D, et al, Short-term oral magnesium supplementation suppresses bone turnover in postmenopausal osteoporotic women. Biol Trace Elem Res. 2010 Feb;133(2):136-43.

Azagra R, Roca G, Encabo G, et al. Prediction of absolute risk of fragility fracture at 10 years in a Spanish population: validation of the WHO FRAX tool in Spain. BMC Musculoskelet Disord. 2011;12:30.

Bab I, Yirmiya R. Depression, selective serotonin reuptake inhibitors, and osteoporosis. Curr Osteoporos Rep. 2010 Dec;8(4):185-91.

Backesjo CM, Li Y, Lindgren U, Haldosen LA. Activation of Sirt1 decreases adipocyte formation during osteoblast differentiation of mesenchymal stem cells. Cells Tissues Organs. 2009;189(1-4):93-7.

Baldini V, Mastropasqua M, Francucci CM, D'Erasmo E. Cardiovascular disease and osteoporosis. J Endocrinol Invest. 2005;28(10 Suppl):69-72.

Banfi G, Lombardi G, Colombini A, Lippi G. Bone metabolism markers in sports medicine. Sports Med. 2010 Aug 1;40(8):697-714.

Barbagallo M, Belvedere M, Dominguez LJ. Magnesium homeostasis and aging. Magnes Res. 2009 Dec;22(4):235-46.

Berga SL, Loucks TL. The diagnosis and treatment of stress-induced anovulation. Minerva Ginecol. 2005 Feb;57(1):45-54.

Binkley N, Harke J, Krueger D, et al. Vitamin K treatment reduces undercarboxylated osteocalcin but does not alter bone turnover, density, or geometry in healthy postmenopausal North American women. J Bone Miner Res. 2009 Jun;24(6):983-91.

Bischoff-Ferrari HA, Dawson-Hughes B, Staehelin HB, et al. Fall prevention with supplemental and active forms of vitamin D: a meta-analysis of randomised controlled trials. BMJ. 2009;339:b3692.

Bischoff-Ferrari HA. How to select the doses of vitamin D in the management of osteoporosis. Osteoporos Int. 2007 Apr;18(4):401-7.

Body JJ, Bergmann P, Boonen S, et al. Non-pharmacological management of osteoporosis: a consensus of the Belgian Bone Club. Osteoporos Int. 2011 Mar 1. [Epub ahead of print]

Boni C, Kordic H, Chaloupka K. Bisphosphonate-associated orbital inflammatory disease and uveitis anterior--a case report and review. Klin Monbl Augenheilkd.Apr 2013;230(4):367-369.

Boots AW, Haenen GR, Bast A. Health effects of quercetin: from antioxidant to nutraceutical. Eur J Pharmacol. 2008 May 13;585(2-3):325-37.

Bredella MA, Torriani M, Ghomi RH, et al. Determinants of bone mineral density in obese premenopausal women. Bone 2011 Apr 1;48(4):748-54.

Brown JP, Morin S, Leslie W, Papaioannou A, Cheung AM, Davison KS, . . . Adachi J. Bisphosphonates for treatment of osteoporosis: expected benefits, potential harms, and drug holidays. Canadian family physician Medecin de famille canadien.2014;60(4):324-333.

Bugel S. Vitamin K and bone health in adult humans. Vitam Horm. 2008;78:393-416.

Bunyaratavej N, Kittimanon N, Jitivirai T, Tongthongthip B. Highly recommended dose of MK4 for osteoporosis. J Med Assoc Thai. 2009 Sep;92 Suppl5:S4-6.

Caldwell JD, Jirikowski GF. Sex hormone binding globulin and aging. Horm Metab Res. 2009 Mar; 41(3): 173-82.

Calomme M, Geusens P, Demeester N, et al. Partial prevention of long-term femoral bone loss in aged ovariectomized rats supplemented with choline-stabilized orthosilicic acid. Calcif Tissue Int. 2006 Apr; 78(4):227-32.

Cawthon PM. Gender Differences in Osteoporosis and Fractures. Clin Orthop Relat Res. 2011 Jan 25.

Celik C, Altunkan S, Yildirim MO, Akyuz M. Relationship between decreased bone mineral density and subclinical atherosclerosis in postmenopausal women. Climacteric. 2010 Jun;13(3):254-8.

Centeno CJ, Busse D, Kisiday J, Keohan C, Freeman M, Karli D. Increased knee cartilage volume in degenerative joint disease using percutaneously implanted, autologous mesenchymal stem cells. Pain Physician. 2008 May-Jun;11(3):343-53.

Chanda D, Kumar S, Ponnazhagan S. Therapeutic potential of adult bone marrow-derived mesenchymal stem cells in diseases of the skeleton. J Cell Biochem. 2010 Oct 1;111(2):249-57.

Chang J, Wang Z, Tang E, et al. Inhibition of osteoblastic bone formation by nuclear factor-kappaB. Nat Med. 2009 Jun;15(6):682-9.

Chehade LK, Curragh D, Selva D. Bisphosphonate-induced orbital inflammation: more common than once thought? Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA.Jan 23 2019.

Cherniack EP, Levis S, Troen BR. Hypovitaminosis D: a widespread epidemic. Geriatrics. 2008 Apr;63(4): 24-30.

Chuin A, Labonte M, Tessier D, et al. Effect of antioxidants combined to resistance training on BMD in elderly women: a pilot study. Osteoporos Int. 2009 Jul;20(7):1253-8.

Clarke BL, Khosla S. Androgens and bone. Steroids. 2009 Mar;74(3):296-305.

Clarke BL, Khosla S. Physiology of bone loss. Radiol Clin North Am. 2010 May;48(3):483-95.

Clinical Key. First Consult; Osteoporosis. 2013; Accessed 10/14/2013.

Confavreux CB, Levine RL, Karsenty G. A paradigm of integrative physiology, the crosstalk between bone and energy metabolisms. Mol Cell Endocrinol. 2009 Oct 30;310(1-2):21-9.

Cutler WB, Friedmann E, Genovese-Stone E. Prevalence of kyphosis in a healthy sample of pre- and postmenopausal women. Am J Phys Med Rehabil. 1993 Aug;72(4):219-25.

D'Amelio P, Isaia G, Isaia GC. The osteoprotegerin/RANK/RANKL system: a bone key to vascular disease. J Endocrinol Invest. 2009;32(4 Suppl):6-9.

Dawson-Hughes B, Heaney RP, Holick MF, et al. Estimates of optimal vitamin D status. Osteoporos Int. 2005 Jul;16(7):713-6.

de Baat P, Heijboer MP, de Baat C. Development, physiology, and cell activity of bone. Ned Tijdschr Tandheelkd. 2005 Jul;112(7):258-63.

de Paula FJ, Horowitz MC, Rosen CJ. Novel insights into the relationship between diabetes and osteoporosis. Diabetes Metab Res Rev. 2010 Nov;26(8):622-30.

Deruelle P, Coulon C. The use of low-molecular-weight heparins in pregnancy--how safe are they? Curr Opin Obstet Gynecol. 2007 Dec;19(6):573-7.

Dhanwal DK, Dennison EM, Harvey NC, Cooper C. Epidemiology of hip fracture: Worldwide geographic variation. Indian J Orthop. 2011 Jan;45(1):15-22.

Diab DL, Watts NB. Long-Term Use of Bisphosphonates in Osteoporosis. The Journal of Clinical Endocrinology & Metabolism.2010;95(4):1555-1565.

Diem SJ, Blackwell TL, Stone KL, et al. Use of antidepressants and rates of hip bone loss in older women: the study of osteoporotic fractures. Arch Intern Med. 2007 Jun 25;167(12):1240-5.

DP, Inc., Data on file.

Drake MT, Cremers SC. Bisphosphonate therapeutics in bone disease: the hard and soft data on osteoclast inhibition. Mol Interv. 2010 Jun;10(3):141-52.

Drieling RL, LaCroix AZ, Beresford SA, Boudreau DM, Kooperberg C, Chlebowski RT, . . . Heckbert SR. Long-term oral bisphosphonate use in relation to fracture risk in postmenopausal women with breast cancer: findings from the Women's Health Initiative. Menopause (New York, N.Y.). Nov 2016;23(11):1168-1175.

Ducharme N. Male osteoporosis. Clin Geriatr Med. 2010 May;26(2):301-9.

Dwyer J. Starting down the right path: nutrition connections with chronic diseases of later life. Am J Clin Nutr. 2006 Feb;83(2):415S-20S.

Ebeling PR. Idiopathic or hypogonadal osteoporosis in men: current and future treatment options. Treat Endocrinol. 2004;3(6):381-91.

Effenberger KE, Johnsen SA, Monroe DG, et al. Regulation of osteoblastic phenotype and gene expression by hop-derived phytoestrogens. J Steroid Biochem Mol Biol. 2005 Sep;96(5):387-99.

El Maghraoui A, Ghazi M, Gassim S, Risk factors of osteoporosis in healthy Moroccan men. BMC Musculoskelet Disord. 2010 Jul 5;11:148.

Englund U, Nordstrom P, Nilsson J, et al. Physical activity in middle-aged women and hip fracture risk: the UFO study. Osteoporos Int. 2011 Feb;22(2):499-505.

Enjuanes A, Ruiz-Gaspa S, Peris P, et al. The effect of the alendronate on OPG/RANKL system in differentiated primary human osteoblasts. Endocrine. 2010 Apr;37(2):322-8.

Ewertz M, Jensen AB. Late effects of breast cancer treatment and potentials for rehabilitation. Acta Oncol. 2011 Feb;50(2):187-93.

Faloon W. Startling Findings About Vitamin D Levels in Life Extension Members. Life Extension Magazine. 2010 Jan;7-14.

Farina EK, Kiel DP, Roubenoff R, et al. Protective effects of fish intake and interactive effects of long-chain polyunsaturated fatty acid intakes on hip bone mineral density in older adults: the Framingham Osteoporosis Study. Am J Clin Nutr. 2011 Mar 2.

Fernandes G, Bhattacharya A, Rahman M, Zaman K, Banu J. Effects of n-3 fatty acids on autoimmunity and osteoporosis. Front Biosci. 2008;13:4015-20.

Ferrari S. Human genetics of osteoporosis. Best Pract Res Clin Endocrinol Metab. 2008 Oct;22(5):723-35.

Fisch C, Attia M, Dargent F, et al. Preclinical assessment of gastrooesophageal tolerance of the new antiosteoporotic drug strontium ranelate: an endoscopic study in monkeys. Basic Clin Pharmacol Toxicol. 2006 May;98(5):442-6

Franke S et al. Advanced glycation endproducts influence the mRNA expression of RAGE, RANKL and various osteoblastic genes in human osteoblasts. Arch Physiol Biochem. 2007 Jun;113(3):154-61.

French DL, Muir JM, Webber CE. The ovariectomized, mature rat model of postmenopausal osteoporosis: an assessment of the bone sparing effects of curcumin. Phytomedicine. 2008 Dec;15(12):1069-78.

Gabbay KH, Bohren KM, Morello R, Bertin T, Liu J, Vogel P. Ascorbate synthesis pathway: dual role of ascorbate in bone homeostasis. J Biol Chem. 2010 Jun 18;285(25):19510-20.

Garland CF, French CB, Baggerly LL, Heaney RP. Vitamin d supplement doses and serum 25-hydroxyvitamin d in the range associated with cancer prevention. Anticancer Res. 2011 Feb;31(2):607-11.

Gennari L, Merlotti D, Martini G,et al. Longitudinal association between sex hormone levels, bone loss, and bone turnover in elderly men. J Ciin Endocrinol Metab. 2003 Nov;88(11):5327-33.

Golden SH, Robinson KA, Saldanha I, Anton B, Ladenson PW. Clinical review: Prevalence and incidence of endocrine and metabolic disorders in the United States: a comprehensive review. J Clin Endocrinol Metab. 2009 Jun;94(6):1853-78.

Graham LS, Parhami F, Tintut Y, Kitchen CM, Demer LL, Effros RB. Oxidized lipids enhance RANKL production by T lymphocytes: implications for lipid-induced bone loss. Clin Immunol. 2009 Nov;133(2):265-75.

Green J, Czanner G, Reeves G, Watson J, Wise L, Beral V. Oral bisphosphonates and risk of cancer of oesophagus, stomach, and colorectum: case-control analysis within a UK primary care cohort. BMJ. 2010; 341:c4444.

Gueldner SH, Britton GR, Madhavan G, et al. Ultrasonometric profiling of incidence and risk of osteoporosis in rural women. J Women Aging. 2008;20(1-2):21-30.

Hagino H. [Epidemiology of osteoporotic fractures]. Clin Calcium. 2003;13(8):995-1002. [Article in Japanese]

Hall SL, Greendale GA. The relation of dietary vitamin C intake to bone mineral density: results from the PEPI study. Calcif Tissue Int. 1998 Sep;63(3):183-9.

Haney EM, Chan BK, Diem SJ, et al. Association of low bone mineral density with selective serotonin reuptake inhibitor use by older men. Arch Intern Med. 2007 Jun 25;167(12):1246-51.

Hanley DA, Cranney A, Jones G, et al. Vitamin D in adult health and disease: a review and guideline statement from Osteoporosis Canada.CMAJ. 2010 Sep 7;182(12):E610-8.

Harkness LS, Fiedler K, Sehgal AR, Oravec D, Lerner E. Decreased bone resorption with soy isoflavone supplementation in postmenopausal women. J Womens Health (Larchmt). 2004 Nov;13(9):1000-7.

He X, Andersson G, Lindgren U, Li Y. Resveratrol prevents RANKL-induced osteoclast differentiation of murine osteoclast progenitor RAW 264.7 cells through inhibition of ROS production. Biochem Biophys Res Commun. 2010 Oct 22;401(3):356-62.

Heaney RP, Armas LA, Shary JR, 25-Hydroxylation of vitamin D3: relation to circulating vitamin D3 under various input conditions. Am J Clin Nutr. 2008 Jun;87(6):1738-42.

Hein G et al. Advanced glycation end product modification of bone proteins and bone remodelling: hypothesis and preliminary immunohistochemical findings. Ann Rheum Dis. 2006 Jan;65(1):101-4.

Hein G, Weiss C, et al. Advanced glycation end product modification of bone proteins and bone remodelling: Hypothesis and preliminary immunohistochemical findings. Ann Rheum Dis. 2006 Jan;65(1):101–4.

Hernandez JL, Olmos JM, Pariente E, et al. Metabolic syndrome and bone metabolism: the Camargo Cohort study. Menopause. 2010 Sep-Oct;17(5):955-61.

Hinshaw WB, DeLong AF. An Evaluative History of Bisphosphonate Drugs: Dual Physiologic Effects of Pyrophosphate as Inspiration for a Novel Pharmaceutical Class. Journal of osteoporosis.2016;2016:7.

Hirao M, Hashimoto J, Ando W, Ono T, Yoshikawa H. Response of serum carboxylated and undercarboxylated osteocalcin to alendronate monotherapy and combined therapy with vitamin K2 in postmenopausal women. J Bone Miner Metab. 2008;26(3):260-4.

Hofle G, Tautermann G, Saely CH, Drexel H. Sex-hormone-binding globulin is negatively correlated with femoral bone-mineral density in male cardiac-transplant recipients. Wien Klin Wochenschr. 2004 Mar 31;116(5-6):170-5.

Holick MF. Optimal vitamin D status for the prevention and treatment of osteoporosis. Drugs Aging. 2007;24(12):1017-29.

Holick MF. Vitamin D deficiency. N Engl J Med. 2007 Jul 19;357(3):266-81.

Hoppe E, Bouvard B, Royer M, Audran M, Legrand E. Sex hormone-binding globulin in osteoporosis. Joint Bone Spine. 2010 Jul;77(4):306-12.

Horcajada-Molteni MN, Crespy V, Coxam V, Davicco MJ, Remesy C, Barlet JP. Rutin inhibits ovariectomy-induced osteopenia in rats. J Bone Miner Res. 2000 Nov;15(11):2251-8.

Howard PA, Barnes BJ, Vacek JL, Chen W, Lai SM. Impact of bisphosphonates on the risk of atrial fibrillation. Am J Cardiovasc Drugs. 2010;10(6):359-67.

Ima-Nirwana S, Suhaniza S. Effects of tocopherols and tocotrienols on body composition and bone calcium content in adrenalectomized rats replaced with dexamethasone. J Med Food. 2004 Spring;7(1):45-51.

Inoue J, Choi JM, Yoshidomi T, Yashiro T, Sato R. Quercetin enhances VDR activity, leading to stimulation of its target gene expression in Caco-2 cells. J Nutr Sci Vitaminol (Tokyo). 2010;56(5):326-30.

Isidori AM, Giannetta E, Greco EA, Effects of testosterone on body composition, bone metabolism and serum lipid profile in middle-aged men: a meta-analysis. Clin Endocrinol (Oxf). 2005 Sep;63(3):280-93.

Iwamoto J, Takeda T, Sato Y. Role of vitamin K2 in the treatment of postmenopausal osteoporosis. Curr Drug Saf. 2006 Jan;1(1):87-97.

Jager M, Wild A, Krauspe R. Osteonecrosis and HELLP-Syndrome. Z Geburtshilfe Neonatol. 2003 Nov-Dec;207(6):213-9.

Janssen HC, Samson MM, Verhaar HJ. Muscle strength and mobility in vitamin D-insufficient female geriatric patients: a randomized controlled trial on vitamin D and calcium supplementation. Aging Clin Exp Res. 2010 Feb;22(1):78-84.

Jeong SH, Choi SH, Kim JY, Koo JW, Kim HJ, Kim JS. Osteopenia and osteoporosis in idiopathic benign positional vertigo. Neurology. 2009 Mar 24;72(12):1069-76.

Ji G, Yang Q, Hao J, et al. Anti-inflammatory effect of genistein on non-alcoholic steatohepatitis rats induced by high fat diet and its potential mechanisms. Int Immunopharmacol. 2011 Feb 12.

Jung SM, Han S, Kwon HY. Dose-Intensity of Bisphosphonates and the Risk of Osteonecrosis of the Jaw in Osteoporosis Patients. Frontiers in pharmacology.2018;9:796.

Kanazawa I, Yamaguchi T, Tada Y, Yamauchi M, Yano S, Sugimoto T. Serum osteocalcin level is positively associated with insulin sensitivity and secretion in patients with type 2 diabetes. Bone. 2011 Apr 1;48(4):720-5.

Kanis JA, Johansson H, Oden A, McCloskey EV. Assessment of fracture risk. Eur J Radiol. 2009 Sep;71(3):392-7.

Kaplan JR, Manuck SB. Ovarian dysfunction, stress, and disease: a primate continuum. ILAR J. 2004;45(2):89-115.

Karabulut AB, Gul M, Karabulut E, Kiran TR, Ocak SG, Otlu O. Oxidant and antioxidant activity in rabbit livers treated with zoledronic acid. Transplant Proc. 2010 Nov;42(9):3820-2.

Katsumi H, Kusamori K, Sakane T, Yamamoto A. [Development of delivery system of bisphosphonates for the treatment of osteoporosis]. Yakugaku Zasshi. 2010 Sep;130(9):1129-33.

Katzman WB, Vittinghoff E, Ensrud K, Black DM, Kado DM. Increasing kyphosis predicts worsening mobility in older community-dwelling women: a prospective cohort study. J Am Geriatr Soc. 2011 Jan;59(1):96-100.

Kawai M, Devlin MJ, Rosen CJ. Fat targets for skeletal health. Nat Rev Rheumatol. 2009 Jul;5(7):365-72.

Kawate H, Takayanagi R. [Secondary osteoporosis UPDATE. Treatment of male osteoporosis. Testosterone replacement therapy etc]. Clin Calcium. 2010 May;20(5):744-51.

Kiecolt-Glaser JK, Preacher KJ, MacCallum RC, et al. Chronic stress and age-related increases in the proinflammatory cytokine IL-6. Proc Natl Acad Sci U S A. 2003 Jul 22;100(15):9090-5.

Kika G, Izumi S, et al. Beneficial aspect of oral estriol as hormone replacement therapy: consideration on bone and lipid metabolism. Tokai J Exp Clin Med. 2009 Sep: 34(2): 92-98.

Kim HY, Choe JW, Kim HK, et al. Negative association between metabolic syndrome and bone mineral density in Koreans, especially in men. Calcif Tissue Int. 2010 May;86(5):350-8.

Kim MH, Bae YJ, Choi MK, Chung YS. Silicon supplementation improves the bone mineral density of calcium-deficient ovariectomized rats by reducing bone resorption. Biol Trace Elem Res. 2009 Jun;128(3):239-47.

Kim MH, Bae YJ, Choi MK, et al. Silicon supplementation improves the bone mineral density of calcium-deficient ovariectomized rats by reducing bone resorption. Biol Trace Elem Res. 2009 Jun;128(3):239-47.

Knapen MH, Schurgers LJ, Vermeer C. Vitamin K2 supplementation improves hip bone geometry and bone strength indices in postmenopausal women. Osteoporos Int. 2007 Jul;18(7):963-72.

Ko SS, Jordan VC. Treatment of osteoporosis and reduction in risk of invasive breast cancer in postmenopausal women with raloxifene. Expert Opin Pharmacother. 2011 Mar;12(4):657-74.

Koitaya N, Ezaki J, Nishimuta M, et al. Effect of low dose vitamin K2 (MK-4) supplementation on bio-indices in postmenopausal Japanese women. J Nutr Sci Vitaminol (Tokyo). 2009 Feb;55(1):15-21.

Kondo K. Beer and health: preventive effects of beer components on lifestyle-related diseases. Biofactors. 2004;22(1-4):303-10.

Kruger MC, Coetzer H, de Winter R, Gericke G, van Papendorp DH. Calcium, gamma-linolenic acid and eicosapentaenoic acid supplementation in senile osteoporosis. Aging (Milano). 1998 Oct;10(5):385-94.

Kupisiewicz K, Boissy P, Abdallah BM, et al. Potential of resveratrol analogues as antagonists of osteoclasts and promoters of osteoblasts. Calcif Tissue Int. 2010 Nov;87(5):437-49.

Kysenius K, Brunello CA, Huttunen HJ. Mitochondria and NMDA receptor-dependent toxicity of berberine sensitizes neurons to glutamate and rotenone injury. PloS one. 2014;9(9):e107129.

Lee AG, Burkat CN, Jirawuthiworavong GV, Chundury RV. Nonspecific Orbital Inflammation (Idiopathic orbital inflammation, Orbital inflammatory syndrome, Orbital pseudotumor). American Academy of Ophthalmology.,_Orbital_inflammatory_syndrome,_Orbital_pseudotumor). Last updated 12/10/2018. Accessed 4/10/2019.

Lee HW, Suh JH, Kim HN, et al. Berberine promotes osteoblast differentiation by Runx2 activation with p38 MAPK. J Bone Miner Res. 2008 Aug;23(8):1227-37.

Lee K, Kim H, Kim JM, et al. Systemic transplantation of human adipose-derived stem cells stimulates bone repair by promoting osteoblast and osteoclast formation. J Cell Mol Med. 2011 Oct; 15(10):2082-94.

Lee SH, Gong HS, Kim TH, Park SY, Shin JH, Cho SW, Byun DW. Position Statement: Drug Holiday in Osteoporosis Treatment with Bisphosphonates in South Korea. Journal of bone metabolism.Nov 2015;22(4):167-174.

Lee YB, Lee HJ, Kim KS, et al. Evaluation of the preventive effect of isoflavone extract on bone loss in ovariectomized rats. Biosci Biotechnol Biochem. 2004 May;68(5):1040-5.

Lefebvre DR, Mandeville JT, Yonekawa Y, Arroyo JG, Torun N, Freitag SK. A Case Series and Review of Bisphosphonate-associated Orbital Inflammation. Ocular immunology and inflammation.2016;24(2):134-139.

Leong KH. Osteoporosis--the need for a paradigm shift. Ann Acad Med Singapore. 1998 Jan;27(1):100-4.

Li B, Zhu WL, Chen KX. Advances in the study of berberine and its derivatives. Yao Xue Xue Bao. 2008 Aug;43(8):773-87.

Li H, Miyahara T, Tezuka Y, et al. The effect of kampo forulae on bone resorption in vitro and in vivo. II. Detailed study of berberine. Biol Pharm Bull. 1999 Apr;22(4):391-6.

Li H, Miyahara T, Tezuka Y, Tran QL, Seto H, Kadota S. Effect of berberine on bone mineral density in SAMP6 as a senile osteoporosis model. Biol Pharm Bull. 2003 Jan;26(1):110-1.

Li N, Li XM, Xu L, Sun WJ, Cheng XG, Tian W. Comparison of QCT and DXA: Osteoporosis Detection Rates in Postmenopausal Women. International journal of endocrinology. 2013;2013:895474.

Li Z, Karp H, Zerlin A, Lee TY, Carpenter C, Heber D. Absorption of silicon from artesian aquifer water and its impact on bone health in postmenopausal women: a 12 week pilot study. Nutr J. 2010;9:44.

Lieben L, Callewaert F, Bouillon R. Bone and metabolism: a complex crosstalk. Horm Res. 2009 Jan;71 Suppl 1:134-8. Epub 2009 Jan 21.

Lim JS, Kim SB, Bang HY, Cheon GJ, Lee JI. High prevalence of osteoporosis in patients with gastric adenocarcinoma following gastrectomy. World J Gastroenterol. 2007 Dec 28;13(48):6492-7.

Lips P, Bouillon R, van Schoor NM, et al. Reducing fracture risk with calcium and vitamin D. Clin Endocrinol (Oxf). 2010 Sep;73(3):277-85.

Liu ZP, Li WX, Yu B, et al. Effects of trans-resveratrol from Polygonum cuspidatum on bone loss using the ovariectomized rat model. J Med Food. 2005 Spring;8(1):14-9.

Lormeau C, Soudan B, d'Herbomez M, Pigny P, Duquesnoy B, Cortet B. Sex hormone-binding globulin, estradiol, and bone turnover markers in male osteoporosis. Bone. 2004 Jun;34(6):933-9.

Ma S, Goh EL, Jin A, Bhattacharya R, Boughton OR, Patel B, . . . Abel RL. Long-term effects of bisphosphonate therapy: perforations, microcracks and mechanical properties. Sci Rep.Mar 6 2017;7:43399.

Maggio M, Artoni A, Lauretani F, et al. The impact of omega-3 fatty acids on osteoporosis. Curr Pharm Des. 2009;15(36):4157-64.

Marcus R, Dempster DW, Cauley JA, Feldman D, Luckey M, eds. Osteoporosis. 4th ed. Vol. 1. Copyright 2013 by Elsevier, Inc.

Marini H, Bitto A, Altavilla D, et al. Breast safety and efficacy of genistein aglycone for postmenopausal bone loss: a follow-up study. J Clin Endocrinol Metab. 2008 Dec;93(12):4787-96.

Martin T, Gooi JH, Sims NA. Molecular mechanisms in coupling of bone formation to resorption. Crit Rev Eukaryot Gene Expr. 2009;19(1):73-88.

Matsui T, Yokoyama A, Matsushita S, et al. Effect of a comprehensive lifestyle modification program on the bone density of male heavy drinkers. Alcohol Clin Exp Res. 2010 May;34(5):869-75.

Matsushita H, Barrios JA, Shea JE, Miller SC. Dietary fish oil results in a greater bone mass and bone formation indices in aged ovariectomized rats. J Bone Miner Metab. 2008;26(3):241-7.

Maziere C, Savitsky V, Galmiche A, et al. Oxidized low density lipoprotein inhibits phosphate signaling and phosphate-induced mineralization in osteoblasts. Involvement of oxidative stress. Biochim Biophys Acta. 2010 Nov;1802(11):1013-9.

McClung M. Is altered bone health part of the metabolic syndrome? Menopause. 2010 Sep-Oct;17(5):900-1.

McFarlane SI, Muniyappa R, Shin JJ, Bahtiyar G, Sowers JR. Osteoporosis and cardiovascular disease: brittle bones and boned arteries, is there a link? Endocrine. 2004 Feb;23(1):1-10.

Mehat MZ, Shuid AN, Mohamed N, Muhammad N, Soelaiman IN. Beneficial effects of vitamin E isomer supplementation on static and dynamic bone histomorphometry parameters in normal male rats. J Bone Miner Metab. 2010 Sep;28(5):503-9.

Mehler PS, Cleary BS, Gaudiani JL. Osteoporosis in anorexia nervosa. Eat Disord. 2011 Mar;19(2):194-202.

Mettler FA, Jr., Huda W, Yoshizumi TT, Mahesh M. Effective doses in radiology and diagnostic nuclear medicine: a catalog. Radiology. Jul 2008;248(1):254-263.

Minaguchi H, Uemua T, Shirasu K, et al. Effect of estriol on bone loss in postmenopausal Japanese women: a multicenter prospective open study. J Obstet Gynaecol Res. 1996;22(3):259-65.

Miranda J. Osteoporosis drugs increase risk for serious heart arrhythmia problems. Presentation Oct. 28, 2008 at CHEST 2008.

Mikes V, Dadak V. Berberine derivatives as cationic fluorescent probes for the investigation of the energized state of mitochondria. Biochimica et biophysica acta. 1983;723(2):231-239.

Mikes V, Yaguzhinskij LS. Interaction of fluorescent berberine alkyl derivatives with respiratory chain of rat liver mitochondria. Journal of bioenergetics and biomembranes. 1985;17(1):23-32.

Mitchner NA, Harris ST. Current and emerging therapies for osteoporosis. J Fam Pract. 2009 Jul;58(7 Suppl Osteoporosis):S45-9.

Mizoguchi T, Nagasawa S, Takahashi N, Yagasaki H, Ito M. Dolomite supplementation improves bone metabolism through modulation of calcium-regulating hormone secretion in ovariectomized rats. J Bone Miner Metab. 2005;23(2):140-6.

Morabito N, Crisafulli A, Vergara C, et al. Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: a randomized double-blind placebo-controlled study. J Bone Miner Res. 2002 Oct;17(10):1904-12.

Morgentaler A. Turning conventional wisdom upside-down: Low Serum testosterone and high-risk prostate cancer. Cancer. 2011 Mar 1.

Morishita M, Nagashima M, Wauke K, Takahashi H, Takenouchi K. Osteoclast inhibitory effects of vitamin K2 alone or in combination with etidronate or risedronate in patients with rheumatoid arthritis: 2-year results. J Rheumatol. 2008 Mar;35(3):407-13.

Mundy GR. Osteoporosis and inflammation. Nutr Rev. 2007 Dec;65(12 Pt 2):S147-51.

Nakhla AM, Hryb DJ, Rosner W, Romas NA, Xiang Z, Kahn SM. Human sex hormone-binding globulin gene expression- multiple promoters and complex alternative splicing. BMC Mol Biol. 2009 May 5;10:37.

National Osteoporosis Foundation. CLINICIAN’S GUIDE TO PREVENTION AND TREATMENT OF OSTEOPOROSIS. Available at: 2013.

Newton KM, LaCroix AZ, Levy L, et al. Soy protein and bone mineral density in older men and women: a randomized trial. Maturitas. 2006 Oct 20;55(3):270-7.

Nielsen FH. Studies on the relationship between boron and magnesium which possibly affects the formation and maintenance of bones. Magnes Trace Elem. 1990;9(2):61-9.

Nishibe A, Morimoto S, Hirota K, et. al. [Effect of estriol and bone mineral density of lumbar vertebrae in elderly and postmenopausal women]. Nippon Ronen Igakkai Zasshi. 1996 May;33(5):353-9.

Nordin BE. The effect of calcium supplementation on bone loss in 32 controlled trials in postmenopausal women. Osteoporos Int. 2009 Dec;20(12):2135-43.

Nozaki M, Hashimoto K, Inoue Y et. al. Usefulness of estriol for the treatment of bone loss in postmenopausal women. Nippon Sanka Fujinka Gakkai Zasshi. 1996 Feb;48(2):83-8.

Nuti R, Merlotti D, Francucci CM, Gennari L. Bone fragility in men: where are we? J Endocrinol Invest. 2010;33(7 Suppl):33-8.

Ofotokun I, Weitzmann MN. HIV-1 infection and antiretroviral therapies: risk factors for osteoporosis and bone fracture. Curr Opin Endocrinol Diabetes Obes. 2010 Dec;17(6):523-9.

Oh S, Kyung TW, Choi HS. Curcumin inhibits osteoclastogenesis by decreasing receptor activator of nuclear factor-kappaB ligand (RANKL) in bone marrow stromal cells. Mol Cells. 2008 Nov 30;26(5):486-9.

Ohta H. Bazedoxifene as a new-generation SERM. Clin Calcium. 2011 Jan;21(1):34-42.

Okura T, Kurata M, Enomoto D, et al. Undercarboxylated osteocalcin is a biomarker of carotid calcification in patients with essential hypertension. Kidney Blood Press Res. 2010;33(1):66-71.

Ortolani S, Scotti A, Cherubini R. Rapid suppression of bone resorption and parathyroid hormone secretion by acute oral administration of calcium in healthy adult men. J Endocrinol Invest. 2003 Apr;26(4):353-8.

Pavese JM, Farmer RL, Bergan RC. Inhibition of cancer cell invasion and metastasis by genistein. Cancer Metastasis Rev. 2010 Sep;29(3):465-82.

Pearson KJ, Baur JA, Lewis KN, et al. Resveratrol delays age-related deterioration and mimics transcriptional aspects of dietary restriction without extending life span. Cell Metab. 2008 Aug;8(2):157-68.

Perez-Castrillon JL, Sagredo MG, Conde R, del Pino-Montes J, de Luis D. OST risk index and calcaneus bone densitometry in osteoporosis diagnosis. J Clin Densitom. 2007 Oct-Dec;10(4):404-7.

Pfeifer M, Begerow B, Minne HW, et al. Effects of a long-term vitamin D and calcium supplementation on falls and parameters of muscle function in community-dwelling older individuals. Osteoporos Int. 2009 Feb;20(2):315-22.

Pirbhai A, Rajak SN, Goold LA, Cunneen TS, Wilcsek G, Martin P, . . . Selva D. Bisphosphonate-Induced Orbital Inflammation: A Case Series and Review. Orbit (Amsterdam, Netherlands).2015;34(6):331-335.

Prouillet C, Maziere JC, Maziere C, Wattel A, Brazier M, Kamel S. Stimulatory effect of naturally occurring flavonols quercetin and kaempferol on alkaline phosphatase activity in MG-63 human osteoblasts through ERK and estrogen receptor pathway. Biochem Pharmacol. 2004 Apr 1;67(7):1307-13.

Rahman MM, Bhattacharya A, Banu J, Kang JX, Fernandes G. Endogenous n-3 fatty acids protect ovariectomy induced bone loss by attenuating osteoclastogenesis. J Cell Mol Med. 2009 Aug;13(8B):1833-44.

Rahman MM, Bhattacharya A, Fernandes G. Docosahexaenoic acid is more potent inhibitor of osteoclast differentiation in RAW 264.7 cells than eicosapentaenoic acid. J Cell Physiol. 2008 Jan;214(1):201-9.

Reese AM, Farnett LE, Lyons RM, et al. Low-dose vitamin k to augment anticoagulation control. Pharmacotherapy. 2005;25(12):1746-51.

Rejnmark L, Vestergaard P, Charles P, et al. No effect of vitamin K1 intake on bone mineral density and fracture risk in perimenopausal women. Osteoporos Int. 2006;17(8):1122-32.

Rezaieyazdi Z, Falsoleiman H, Khajehdaluee M, Saghafi M, Mokhtari-Amirmajdi E. Reduced bone density in patients on long-term warfarin. Int J Rheum Dis. 2009 Jul;12(2):130-5.

Rhoden EL, Morgentaler A. Risks of testosterone-replacement therapy and recommendations for monitoring. N Engl J Med. 2004 Jan 29;350(5):482-92.

Roelofs AJ, Thompson K, Ebetino FH, Rogers MJ, Coxon FP. Bisphosphonates: molecular mechanisms of action and effects on bone cells, monocytes and macrophages. Curr Pharm Des. 2010;16(27):2950-60.

Rubinacci A. Expanding the functional spectrum of vitamin K in bone. Focus on: “Vitamin K promotes mineralization, osteoblast to osteocyte transition, and an anti-catabolic phenotype by y-carboxylation-dependent and -independent mechanisms”. Am J Physiol Cell Physiol December 2009 vol. 297 no. 6 C1336-C1338

Ruiz-Ramos M, Vargas LA, et al. Supplementation of ascorbic acid and alpha-tocopherol is useful to preventing bone loss linked to oxidative stress in elderly. J Nutr Health Aging. 2010 Jun;14(6):467-72.

Sacco SM, Jiang JM, Reza-Lopez S, Ma DW, Thompson LU, Ward WE. Flaxseed combined with low-dose estrogen therapy preserves bone tissue in ovariectomized rats. Menopause. 2009 May-Jun;16(3):545-54.

Salaffi F, Silveri F, Stancati A, Grassi W. Development and validation of the osteoporosis prescreening risk assessment (OPERA) tool to facilitate identification of women likely to have low bone density. Clin Rheumatol. 2005 Jun;24(3):203-11.

Salari P, Rezaie A, Larijani B, Abdollahi M. A systematic review of the impact of n-3 fatty acids in bone health and osteoporosis. Med Sci Monit. 2008 Mar;14(3):RA37-44.

Salari Sharif P, Asalforoush M, Ameri F, Larijani B, Abdollahi M. The effect of n-3 fatty acids on bone biomarkers in Iranian postmenopausal osteoporotic women: a randomized clinical trial. Age (Dordr). 2010 Jun;32(2):179-86.

Santos L, Romeu JC, Canhão H, et al. A quantitative comparison of a bone remodeling model with dual-energy X-ray absorptiometry and analysis of the inter-individual biological variability of femoral neck T-score. J Biomech. 2010 Dec;43(16):3150-5.

Sato Y, Honda Y, Kaji M, et al. Amelioration of osteoporosis by menatetrenone in elderly female Parkinson’s disease patients with vitamin D deficiency. Bone. 2002 Jul;31(1):114-8.

Scorei R, Cimpoiasu VM, Iordachescu D. In vitro evaluation of the antioxidant activity of calcium fructoborate. Biol Trace Elem Res. 2005 Nov;107(2):127-34.

Scorei RI, Rotaru P. Calcium Fructoborate-Potential Anti-inflammatory Agent. Biol Trace Elem Res. 2011 Jan 28. [Epub ahead of print]

Sedghizadeh PP, Stanley K, Caligiuri M, et al. Oral bisphosphonate use and the prevalence of osteonecrosis of the jaw: an institutional inquiry. J Am Dent Assoc. 2009 Jan;140(1):61-6.

Seeman E. The structural basis of bone fragility in men. Bone. 1999 Jul;25(1):143-7.

Sehmisch S, Erren M, Kolios L, et al. Effects of isoflavones equol and genistein on bone quality in a rat osteopenia model. Phytother Res. 2010 Jun;24 Suppl 2:S168-74.

Sehmisch S, Uffenorde J, Maehlmeyer S, et al. Evaluation of bone quality and quantity in osteoporotic mice--the effects of genistein and equol. Phytomedicine. 2010 May;17(6):424-30.

Seymour GJ, Ford PJ, Cullinan MP, Leishman S, Yamazaki K. Relationship between periodontal infections and systemic disease. Clin Microbiol Infect. 2007 Oct;13 Suppl 4:3-10.

Shakibaei M, Buhrmann C, Mobasheri A. Resveratrol-mediated SIRT-1 Interactions with p300 Modulate Receptor Activator of NF-{kappa}B Ligand (RANKL) Activation of NF-{kappa}B Signaling and Inhibit Osteoclastogenesis in Bone-derived Cells. J Biol Chem. 2011 Apr 1;286(13):11492-505.

Shiraki M, Itabashi A. Short-term menatetrenone therapy increases gamma-carboxylation of osteocalcin with a moderate increase of bone turnover in postmenopausal osteoporosis: a randomized prospective study. J Bone Miner Metab. 2009;27(3):333-40.

Shishodia S, Sethi G, Aggarwal BB. Curcumin: getting back to the roots. Ann N Y Acad Sci. 2005 Nov;1056:206-17.

Shuid AN, Mehat Z, Mohamed N, Muhammad N, Soelaiman IN. Vitamin E exhibits bone anabolic actions in normal male rats. J Bone Miner Metab. 2010 Mar;28(2):149-56.

Silverman SL. New selective estrogen receptor modulators (SERMs) in development. Curr Osteoporos Rep. 2010 Sep;8(3):151-3.

Sioka C, Fotopoulos A, Georgiou A, Xourgia X, Papadopoulos A, Kalef-Ezra JA. Age at menarche, age at menopause and duration of fertility as risk factors for osteoporosis. Climacteric. 2010 Feb;13(1):63-71.

Smith MR, McGovern FJ, Fallon MA, Schoenfeld D, Kantoff PW, Finkelstein JS. Low bone mineral density in hormone-naïve men with prostate carcinoma. Cancer. 2001 Jun 15;91(12):2238-45.

Sogabe N, Maruyama R, Baba O, Hosoi T, Goseki-Sone M. Effects of long-term vitamin K(1) (phylloquinone) or vitamin K(2) (menaquinone-4) supplementation on body composition and serum parameters in rats. Bone. 2011 Feb 2.

Sojka 1995

Song LH, Pan W, Yu YH, Quarles LD, Zhou HH, Xiao ZS. Resveratrol prevents CsA inhibition of proliferation and osteoblastic differentiation of mouse bone marrow-derived mesenchymal stem cells through an ER/NO/cGMP pathway. Toxicol In Vitro. 2006 Sep;20(6):915-22.

Spangler M, Phillips BB, Ross MB, Moores KG. Calcium supplementation in postmenopausal women to reduce the risk of osteoporotic fractures. Am J Health Syst Pharm. 2011 Feb 15;68(4):309-18.

Spector TD, Calomme MR, Anderson SH, et al. Choline-stabilized orthosilicic acid supplementation as an adjunct to calcium/vitamin D3 stimulates markers of bone formation in osteopenic females: a randomized, placebo-controlled trial. BMC Musculoskelet Disord. 2008;Jun 11; 9:85.

Stevens JF, Page JE. Xanthohumol and related prenylflavonoids from hops and beer: to your good health! Phytochemistry. 2004 May;65(10):1317-30.

Straub DA. Calcium supplementation in clinical practice: a review of forms, doses, and indications. Nutr Clin Pract. 2007 Jun;22(3):286-96.

Sugiura M, Nakamura M, Ogawa K, et al. Dietary patterns of antioxidant vitamin and carotenoid intake associated with bone mineral density: findings from post-menopausal Japanese female subjects. Osteoporos Int. 2011 Jan;22(1):143-52.

Sun L, Tamaki H, Ishimaru T, et al. Inhibition of osteoporosis due to restricted food intake by the fish oils DHA and EPA and perilla oil in the rat. Biosci Biotechnol Biochem. 2004 Dec;68(12):2613-5.

Sveinsdóttir H, Olafsson RF. Women's attitudes to hormone replacement therapy in the aftermath of the Women's Health Initiative study. J Adv Nurs. 2006 Jun;54(5):572-84.

Tan M, Kalin-Hajdu E, Narayan R, Wong SW, Martin TG. Zoledronic acid-induced orbital inflammation in a patient with multiple myeloma. J Oncol Pharm Pract.Jan 1 2018:1078155218785967.

Tanikawa T et al. Advanced glycation end products induce calcification of vascular smooth muscle cells through RAGE/p38 MAPK. J Vasc Res. 2009;46(6):572-80.

Tracz MJ, Sideras K, Boloña ER, et al. Testosterone use in men and its effects on bone health. A systematic review and meta-analysis of randomized placebo-controlled trials. J Clin Endocrinol Metab. 2006 Jun;91(6):2011-6.

Trebble TM, Arden NK, Wootton SA, et al. Fish oil and antioxidants alter the composition and function of circulating mononuclear cells in Crohn disease. Am J Clin Nutr. 2004 Nov;80(5):1137-44.

Tremollieres F, Ribot C. Bone mineral density and prediction of non- osteoporotic disease. Maturitas. 2010 Apr;65(4):348-51.

Tsuang YH, Sun JS, Chen LT, Sun SC, Chen SC. Direct effects of caffeine on osteoblastic cells metabolism: the possible causal effect of caffeine on the formation of osteoporosis. J Orthop Surg Res. 2006;1:7.

Tucker KL, Morita K, Qiao N, et al. Colas, but not other carbonated beverages, are associated with low bone mineral density in older women: The Framingham Osteoporosis Study. Am J Clin Nutr. 2006 Oct;84(4):936-42.

Uesugi T, Fukui Y, Yamori Y. Beneficial effects of soybean isoflavone supplementation on bone metabolism and serum lipids in postmenopausal japanese women: a four-week study. J Am Coll Nutr. 2002 Apr;21(2):97-102.

Valcourt U et al. Non-enzymatic glycation of bone collagen modifies osteoclastic activity and differentiation. J Biol Chem. 2007 Feb 23;282(8):5691-703.

Varenna M, Gatti D. [The role of rank-ligand inhibition in the treatment of postmenopausal osteoporosis]. Reumatismo. 2010 Jul-Sep;62(3):163-71.

Vermeer C, Shearer MJ, Zittermann A, et al. Beyond deficiency: potential benefits of increased intakes of vitamin K for bone and vascular health. Eur J Nutr. 2004 Dec;43(6):325-35.

Vibert D, Kompis M, Hausler R. Benign paroxysmal positional vertigo in older women may be related to osteoporosis and osteopenia. Ann Otol Rhinol Laryngol. 2003 Oct;112(10):885-9.

Vibert D, Sans A, Kompis M, et al. Ultrastructural changes in otoconia of osteoporotic rats. Audiol Neurootol. 2008;13(5):293-301.

Volpe SL, Taper LJ, Meacham S. The relationship between boron and magnesium status and bone mineral density in the human: a review. Magnes Res. 1993 Sep;6(3):291-6.

Von Muhlen D et al. Effect of dehydroepiandrosterone supplementation on bone mineral density, bone markers, and body composition in older adults: the DAWN trial. Osteoporos Int. 2008 May;19(5):699-707. Epub 2007 Dec 15.

Vora MM, Rodgers IR, Uretsky S. Nitrogen bisphosphonate-induced orbital inflammatory disease: gamma delta T cells-a report and review of 2 cases. Ophthalmic Plast Reconstr Surg.Jul-Aug 2014;30(4):e84-85.

Wada S, Fukawa T, Kamiya S. [Osteocalcin and bone]. Clin Calcium. 2007 Nov; 17(11):1673-7.

Walker J. The role of the nurse in the management of osteoporosis. Br J Nurs. 2010 Oct 28-Nov 10;19(19):1243-7.

Ward WE, Fonseca D. Soy isoflavones and fatty acids: effects on bone tissue postovariectomy in mice. Mol Nutr Food Res. 2007 Jul;51(7):824-31.

Wattel A, Kamel S, Prouillet C, et al. Flavonoid quercetin decreases osteoclastic differentiation induced by RANKL via a mechanism involving NF kappa B and AP-1. J Cell Biochem. 2004 May 15;92(2):285-95.

Weaver CM, Martin BR, Jackson GS, et al. Antiresorptive effects of phytoestrogen supplements compared with estradiol or risedronate in postmenopausal women using (41)Ca methodology. J Clin Endocrinol Metab. 2009 Oct;94(10):3798-805.

Weiss EP, Shah K, Fontana L, et al. Dehydroepiandrosterone replacement therapy in older adults: 1- and 2-y effects on bone. Am J Clin Nutr. 2009 May;89(5):1459-67. Epub 2009 Mar 25.

Whitaker M, Guo J, Kehoe T, Benson G. Bisphosphonates for Osteoporosis — Where Do We Go from Here? New England Journal of Medicine.2012;366(22):2048-2051.

Wylie CD. Setting a standard for a "silent" disease: defining osteoporosis in the 1980s and 1990s. Stud Hist Philos Biol Biomed Sci. 2010 Dec;41(4):376-85.

Xu D, Yang W, Zhou C, Liu Y, Xu B. Preventive effects of berberine on glucocorticoid-induced osteoporosis in rats. Planta Med. 2010 Nov;76(16):1809-13.

Xu P, Hu WB, Guo X, et al. [Therapeutic effect of dietary boron supplement on retinoic acid-induced osteoporosis in rats]. Nan Fang Yi Ke Da Xue Xue Bao. 2006 Dec;26(12):1785-8.

Yang MW, Wang TH, Yan PP, et al. Curcumin improves bone microarchitecture and enhances mineral density in APP/PS1 transgenic mice. Phytomedicine. 2011 Jan 15;18(2-3):205-13.

Yang YJ, Yang ZL, Wang DC, Xiao XC, Li P. [Comparative study on effects of rutin and quercetin on metabolism in osteoblast cells]. Zhong Yao Cai. 2006 May;29(5):467-70.

Yasui T, Miyatani Y, Tomita J, et al. Effect of vitamin K2 treatment on carboxylation of osteocalcin in early postmenopausal women. Gynecol Endocrinol. 2006 Aug;22(8):455-9.

Yu EW, Thomas BJ, Brown JK, Finkelstein JS. Simulated increases in body fat and errors in bone mineral density measurements by DXA and QCT. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research. Jan 2012;27(1):119-124.

Zhou Z and Xiong WC. RAGE and its ligands in bone metabolism. Front Biosci (Schol Ed). 2011 Jan 1;3:768-76.

Zinnuroglu M, Dincel AS, Kosova F, Sepici V, Karatas GK. Prospective evaluation of free radicals and antioxidant activity following 6-month risedronate treatment in patients with postmenopausal osteoporosis. Rheumatol Int. 2011 Jan 8.

zur Nieden NI. Embryonic stem cells for osteo-degenerative diseases. Methods Mol Biol. 2011;690:1-30.